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Detachment of the rear of the cell from its substratum is an important aspect of locomotion. The
signaling routes involved in this adhesive release are largely unknown. One of the few candidate
proteins to play a role is RhoA, because activation of RhoA in many cell types leads to contraction,
a mechanism probably involved in detachment. To study the role of RhoA in detachment
regulation, we analyzed several subsets of expert migratory leukocytes by video microscopy. In
contrast to fast-migrating neutrophils, eosinophils do not detach the rear of the cell unless
stimulated with serum. When measuring the amount of active RhoA, with the use of a GST-
Rhotekin pulldown assay, we found that serum is an excellent activator of RhoA in granulocytes.
Inhibition of RhoA or one of Rho’s target proteins, the kinase ROCK, in neutrophils leads to the
phenotype seen in eosinophils: the rear of the cell is firmly attached to the substratum, whereas
the cell body is highly motile. ROCK-inhibition leads to impaired migration of granulocytes in
filters, on glass, and through endothelial monolayers. Also, the ROCK signaling pathway is
involved in changes of integrin-mediated adhesion. Eosinophil transduction by a tat-fusion
construct containing active RhoA resulted in detachment stimulation in the presence of chemoat-
tractant. From these results we conclude that activation of the RhoA-ROCK pathway is essential
for detachment of migratory leukocytes.
INTRODUCTION
When a eukaryotic cell migrates, the leading lamella pro-
trudes, then the cell body moves forward, and finally the
rear of the cell (or uropod) releases the binding from the
extracellular environment. When the process of rear release
is slow compared with the protrusion of the leading lamella,
it will determine the migration rate (Lauffenburger and Hor-
witz, 1996). The mechanisms by which adhesions release are
largely unknown. First, cytoskeletal contraction may over-
come the negative force that is exerted by the adhesion
molecules bound to the extracellular matrix. Contraction of
actin filaments can pull on filaments connected to integrins
that link the cell to the extracellular matrix (Small et al.,
1999). Alternatively, ligand-induced signaling is proposed to
play a role in adhesive release. Calcineurin, a calcium-reg-
ulated serine-threonine phosphatase, plays a role in recy-
cling of integrins in neutrophils (Lawson and Maxfield,
1995). Also implicated in adhesive release is RhoA: inhibi-
tors of RhoA induce cytoskeletal breakdown and cell round-
ing (Jalink et al., 1994) and inhibit migration in several cell
types (Allen et al., 1998).
RhoA is a member of the Ras superfamily of small GTP-
binding proteins that regulate formation of actin stress fibers
and focal adhesions. RhoA activation can be blocked by the
ADP-ribosyltransferase from Clostridium botulinum, C3-ex-
oenzyme. In this way the importance of RhoA in several
cellular processes, such as cell morphology, migration, cy-
tokinesis, DNA-synthesis, and cell growth, was established
(reviewed in Hall, 1998). Like Ras, RhoA cycles between a
GDP-bound inactive state and a GTP-bound active state.
RhoA-bound nucleotides are regulated by several groups of
proteins: guanine nucleotide exchange factors, GTPase-acti-
vating proteins, and guanine nucleotide dissociation inhib-
itors. When GTP-bound, RhoA binds to and activates a
number of downstream effectors (Aspenstro¨m, 1999) such as
Rho kinase, lipid kinases, and Rhophilin.
Rho kinase, also known as ROCKII or ROKa is closely
related to p160ROCK (ROCKI) or ROKb (Ishizaki et al.,
1996). ROCKII is implicated to mediate actomyosin-based
contractility stimulated by RhoA. It phosphorylates myosin
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phosphatase, resulting in elevated myosin light chain (MLC)
phosphorylation (Kimura et al., 1996). MLC phosphorylation
is correlated with myosin II filament assembly and actin-
activated myosin ATPase activity (Chrzanowska-Wodnicka
and Burridge, 1996). Apart from this, Rho kinase may also
phosphorylate MLC directly (Amano et al., 1996). With the
use of the specific inhibitor Y27632, ROCKs were shown to
be important for many of the Rho-mediated cellular pro-
cesses, including smooth muscle contraction (Uehata et al.,
1997), myosin light chain phosphorylation (Klages et al.,
1999), tumor cell invasion (Itoh et al., 1999), and motility
(Niggli, 1999).
Until recently, RhoA activity was established by the ap-
pearance of stress fibers or focal adhesions. In leukocytes
however, stress fibers and focal adhesions are not formed.
Several groups have now published an activation assay for
RhoA, with the use of the RhoA-binding domain of Rho-
tekin (Reid et al., 1996), and were able to show RhoA acti-
vation upon stimulation of 3T3 cells with the integrin ligand
fibronectin or with lysophosphatidic acid (Ren et al., 1999;
Sander et al., 1999).
We have studied the role of RhoA and its downstream
kinase ROCK in the process of detachment of highly motile
leukocyte subsets. Serum stimulation of detachment-defec-
tive eosinophils leads to RhoA-activation and enhanced mi-
gration. Inhibition of RhoA or ROCK in motile neutrophils
results in a phenotype similar to eosinophils: the leading
lamella is protruding, whereas the rear of the cell stays
firmly attached to the substratum. Furthermore, we investi-
gated the effects of ROCK activity on adhesion. The results
are discussed with respect to the theoretical background of
rear release and its role during cell migration.
MATERIALS AND METHODS
Reagents and Antibodies
Eotaxin was obtained from R&D Systems (Abingdon, United King-
dom); platelet-activating factor (PAF) (1-O-hexadecyl-2-acetyl-sn-
glycero-3-phosphoryl-choline) and formyl-methionyl-leucyl-phe-
nylalanine (fMLP) were from Sigma (St. Louis, MO); recombinant
human interleukin-5 (IL-5) was a gift from M. McKinnon (Glaxo-
SmithKline, Stevenage, United Kingdom); Ficoll-paque and Percoll
were from Amersham Pharmacia Biotech (Uppsala, Sweden); hu-
man serum albumin (HSA) and pasteurized plasma solution were
from CLB (Amsterdam, The Netherlands); calcein-AM and Alexa-
phalloidin were from Molecular Probes (Eugene, OR); vascular cell
adhesion molecule-1 (VCAM-1) and intercellular adhesion mole-
cule-1 (ICAM-1) were from R&D Systems; neutralizing antibodies
against a4-integrin (HP2/1) were from Immunotech (Marseille,
France); antibodies against b2-integrins (IB4) were isolated from
culture medium of hybridoma obtained from the American Type
Culture Collection (Rockville, MD); anti-RhoA was from Santa Cruz
Biotechnologies (Santa Cruz, CA), anti-phospho-Erk1/2, anti-phos-
pho-p38, and anti-phospho-protein kinase B (PKB) were from Bio-
Labs (Surrey, Canada). The ROCK-inhibitor Y27632 was kindly
provided by Welfide (Osaka, Japan).
Cell Isolation
Blood was obtained from healthy volunteers via the Red Cross
Blood Bank (Utrecht, The Netherlands). Eosinophils were isolated
as previously described (Koenderman et al., 1988). In short, buffy
coats of citrate-anticoagulated (0.4% wt/vol) blood were subjected
to Ficoll centrifugation. Erythrocytes were removed by isotonic
shock (NH4Cl), and the mixed granulocyte fraction, after 10-min
treatment with fMLP (1028 M), was subjected to discontinuous
Percoll gradient (1.082/1.1 g/ml) centrifugation. Dense eosinophils
were washed once with phosphate-buffered saline (PBS) containing
0.3% citrate and 10% pasteurized plasma then taken up in RPMI-
HEPES supplemented with 0.5% HSA. They were .95% pure and
.98% viable. Cell viability was not affected by treatment with
Y27632 (100 mM) for up to 2.5 h.
Video Microscopy and Tracking of Granulocytes
Glass coverslips (0.3 mm) were coated with a solution of 1% HSA.
Purified neutrophils or eosinophils, suspended in RPMI-HEPES
with 0.5% HSA were attached to the coverslip for 10–15 min at room
temperature. The coverslip was then inverted in a droplet of me-
dium containing the desired ligands or antibodies and sealed with
a mixture of beeswax, paraffin, and petroleum jelly (1:1:1, wt/wt/
wt). Cell migration at 37°C was monitored by time-lapse micro-
scopy and analyzed by custom-made macro (A.L.I.) in image anal-
ysis software (Optimas 6.2; Media Cybernetics, Silver Spring, MD).
Cells were followed for 8 min (Figures 1 and 3) or 20 min (Figure 7).
As expected with the use of primary cells, a heterogeneous popu-
lation of different age and priming, there is variation in the rate and
the amount of movement seen in the figures. However, the results
shown are representative for a larger field of cells (usually 50–100
cells) and repeated at least three times for every assay condition.
RhoA Activation Assay
RhoA activity assay was performed as described (Sander et al.,
1999). Neutrophils or eosinophils were stimulated in suspension
then lysed in 50 mM Tris pH 7.5, 150 mM NaCl, 10% glycerol, 1%
NP-40, 0.1% Triton X-100, 5 mM MgCl2, 0.1 mM phenylmethylsul-
fonyl fluoride, 10 mg/ml leupeptine, 10 mg/ml aprotinin). Cleared
lysates were incubated with bacterially produced GST-RBD[Rho-
tekin] (Reid et al., 1996) bound to glutathion-agarose beads for 45
min at 4°C. The beads were washed three times with lysis buffer
then bound proteins were eluted in SDS-sample buffer and analyzed
by Western blotting with the use of anti-RhoA monoclonal antibody
from Santa Cruz Biotechnologies.
Migration Assay with Use of Boyden Chamber
Eosinophil migration was measured in the modified Boyden cham-
ber assay exactly as described (Schweizer et al., 1996). Cellulose
nitrate filters (pore width, 8 mm; thickness, 150 mm; Sartorius, Goet-
tingen, Germany) were soaked in 0.5% HSA. The assays were per-
formed in HEPES-buffered RPMI (Life Technologies, Breda, The
Netherlands) supplemented with 0.5% HSA for 2.5 h at 37°C in a
CO2 incubator. Filters were fixed, stained with hematoxilin
(Weigert’s method), and embedded in malinol. Analysis of the
filters was done by an image analysis system (Quantimet 570 C) and
an automated microscope to score the number of cells at 15 intervals
of 10 mm in the Z-direction of the filters. The results are expressed
as the chemotactic index, indicating the mean migrated distance
(mm), excluding cells with migration zero.
Transendothelial Migration
Human umbilical vein endothelial cells were plated in Transwell
chambers (Costar, Bucks, UK; pore width, 8 mm; diameter, 6
mm), coated with fibronectin. When confluence was reached,
purified eosinophils (105/well) were calcein-AM (Molecular
Probes) loaded according to the manufacturer, washed, resus-
pended in RPMI-HEPES, and placed in the upper wells. The
lower wells were filled with RPMI-HEPES containing the che-
moattractant. The chambers were placed for 1 h at 37°C in a CO2
incubator. At the end of the experiment, the migrated cells in the
lower wells, the inserts, as well as the cells from the upper wells
were lysed in 1% Triton-X100-containing buffer. Fluorescence
intensities were measured with the use of a FluorImager (Molec-
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ular Dynamics, Sunnyvale, CA). Standard curves with the use of
fixed amounts of calcein-AM-loaded cells were prepared each
time. Values are given as the percentage of migrated cells of total
cells loaded.
Adhesion Assay
Static adhesion of eosinophils was performed in 96-well Elisa plates
(Nunc, Naperville, CT), coated for 1 h at room temperature with
Figure 1. Cell tracks of randomly moving eosinophils (A, B, C, G, and H) and neutrophils (D–F). The cells were attached to albumin-coated glass
coverslips in RPMI-HEPES containing 0.5% HSA. Then they were transferred to the same buffer completed as indicated without stimulus (A and
D) with PAF (1027 M; B and G), fMLP (1028 M; E), or 10% human pooled serum (C, F, and H). The cells were warmed to 37°C and then monitored
for 20 min (A–C), 8 min (D–F), or 30 min (G and H). Bar, 30 mm (A–F) or 10 mm (G and H). Video material available for A–H.
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0.1% HSA or VCAM-1 (5 mg/ml) in PBS. Cells were calcein-AM
loaded, incubated with antibody or inhibitors, and added to the
wells already containing medium with or without serum. After 5
min, the plates were placed at 37°C for 5 min then they were washed
once with PBS containing 0.1% bovine serum albumin and lysed in
TX-100 containing buffer. Remaining cells were quantified with the
use of a FluorImager.
Tat-Fusion Constructs
Polymerase chain reaction products comprising the coding region of
constitutively active V14RhoA, dominant negative N19RhoA, or
dominant negative N17Rac-1 (Hall, 1998) were cloned into the
pTAT-HA vector (Nagahara et al., 1998), sequenced, and trans-
formed into the BL21(DE3) strain. Bacteria were obtained from a
overnight culture, resuspended and sonicated in Z-buffer (8 M urea,
100 mM NaCl, and 20 mM HEPES, pH 8.0), and supernatants
containing 10 mM imidazol were loaded onto a Ni-NTA column
(Qiagen, Chatsworth, CA). Tat-fusion proteins were eluted with 1 M
imidazol in Z buffer, diluted five times with 20 mM HEPES buffer
pH 8.0 and applied to a Source 30Q column (Amersham Pharmacia
Biotech). After washing, bound proteins were eluted with 1 M NaCl,
desalted on a PD-10 columns into PBS/1 mM CaCl2, flash frozen in
10% glycerol, and stored at 280°C.
With the use of tat-V14RhoA constructs in eosinophil migration
assays, such as shown in Figure 7, we found in a minority of the
experiments no effect of the tat-constructs, which we cannot explain.
The effects of tat-V14 Rho decreased after incubations of .45 min.
RESULTS
Imaging of Cellular Detachment
To study the migration of expert migratory leukocytes, we
performed video microscopy on human eosinophils. Track-
ing of cells attached to albumin-coated glass slides allows
the study of speed, direction, and morphology of each cell.
Figure 1 shows the tracks of eosinophils and neutrophils
migrating in the absence or the presence of stimulus. Eosin-
ophils in the control situation, or when stimulated with the
chemoattractant PAF, are highly motile. In these circum-
stances eosinophils move the cell body but are not able to
detach the uropod and therefore hardly migrate (Figure 1G;
also see video). Whereas the addition of chemoattractants
has no effect on eosinophil detachment, serum-stimulation
of the cells leads to rear release. More cells were able to
detach their uropod, resulting in a higher mean migration
speed, as can be concluded from the longer tracks. Neutro-
phils, however, are optimally stimulated with the chemoat-
tractant fMLP and serum does not further enhance neutro-
phil migration (Figure 1, D–F).
Involvement of RhoA in Detachment of Uropods
Because serum is able to stimulate detachment, we hypoth-
esized that serum may activate the RhoA-ROCK pathway.
We used a recently developed RhoA activation assay (Sand-
er et al., 1999) to test this hypothesis. In this assay a GST-
Rhotekin pulldown is performed on lysates of activated
leukocytes then the amount of active RhoA present in the
cells is determined by Western blotting. Figure 2 shows that
serum is an excellent activator of RhoA, both in neutrophils
and eosinophils. Compared with serum, the activity of
RhoA after stimulation by the chemoattractant fMLP and
PAF is rather weak. However, these latter experiments show
that a relatively small and transient activation of RhoA per
se is not sufficient for rear release (see below). These results
indicate that increased detachment observed after serum
stimulation correlates with strong RhoA activation. This
RhoA activation is not dependent on a cycle of attachment
and detachment because the experiments were performed
with cells in suspension.
To determine whether RhoA is involved in stimulation of
detachment, we used a specific inhibitor of RhoA, C3-exoen-
zyme. We studied the migration of neutrophils because
these cells have no rear release problems when monitored
on a glass coverslip in the presence of chemoattractant.
Figure 3A shows tracks of neutrophils that were control
treated or preincubated with C3-exoenzyme (Figure 3B).
Those cells show a morphology similar to eosinophils: the
uropod is attached, but the cell body is still highly motile, as
can be seen in the videos. These results indicate that RhoA is
involved in cellular detachment of the uropod.
ROCKs Are Involved in Rear Release Regulation
ROCKI and II are downstream targets of RhoA involved in
MLC phosphorylation and thereby in force generation and
contraction of cells. To investigate whether ROCKs are in-
volved in detachment, we used the ROCK-inhibitor Y27632
(Uehata et al., 1997) in several migration assays. Figure 3C
and D shows tracks of neutrophils that are stimulated with
fMLP either in the absence or in the presence of Y27632.
After ROCK-inhibition by Y27632, the cells show a de-
creased net cell translocation and thus a decreased mean
migration speed, which can be concluded from the track
length. However, these cells are still highly motile, as can be
seen in the videos provided with Figure 3. The uropod of the
cells is again attached to the substratum, whereas the cell
body moves around it. It is obvious that the cells treated
with Y27632 cannot detach. The specificity of the ROCK
inhibitor Y27632 is tested in vitro by Uehata et al. (1997).
Several important kinases were tested: PKC, PKA, MLCK,
and PAK. Furthermore, Y27632 did not have any effect on
RhoA-dependent transcription and Rac-dependent mem-
brane ruffling. In neutrophils, we tested fMLP-stimulated
Figure 2. RhoA activation assay in neutrophils and eosinophils.
The cells were stimulated with fMLP (1027 M), PAF (1027 M), or
serum for the time-periods indicated, lysed, and subjected to GST-
Rhotekin pulldown as described in MATERIALS AND METHODS.
Shown are Western blots of active RhoA (arrow).
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activation of PKB, Erk1/2, and p38 (Figure 3E). We found no
inhibitory effect of Y27632 on these key signaling routes.
Importance of ROCKs during Transendothelial
Migration
Migration of eosinophils across a monolayer of endothelial
cells is complicated by the fact that the endothelial cells not
only form the substrate over which the eosinophils have to
move and the barrier they have to cross but also the endo-
thelial cells provide signals to the eosinophils, for instance,
by secreted chemokines. In the past, attention has focussed
on the role of RhoA and Rho kinase in the contraction and
permeability of endothelial cell layers (Essler et al., 1998). We
investigated the involvement of ROCK in eosinophils when
Figure 3. Migration of neutrophils on al-
bumin-coated glass coverslips. The cells
were untreated (A and C) or pretreated with
C3-exoenzyme (10 mg/ml; 4 h, B) or Y27632
(1025 M; 30 min, D) then attached to the
coverslips. The coverslips were inverted in
assay medium containing fMLP (1028 M)
and embedded. Random movement of the
cells was recorded at 20-s intervals. Shown
are tracks recorded during an 8-min period.
Bar, 30 mm. (E) fMLP-induced activity of
Erk1/2, p38, and PKB in neutrophils in the
absence or presence of Y27632 (1025 M; 30
min) with the use of phosphospecific anti-
bodies. Video material available for A–D.
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transmigrating an endothelial cell layer in the absence of
serum. Figure 4 shows a transwell assay performed on eo-
sinophils pretreated with Y27632. The transmigration (top)
induced by PAF or eotaxin is completely blocked by Y27632
at 100 mM, whereas the control values are hardly affected.
Analysis of the filters (middle) shows that after inhibition of
ROCK by Y27632, a considerable number of cells remain
present in the filter, independent of the stimulus. This could
indicate an increase of adhesion of eosinophils to the endo-
thelial cells or a decreased detachment. To rule out the first
possibility, we performed adhesion assays of eosinophils to
endothelial monolayers. We never found an increased ad-
hesion after Y27632 treatment (unpublished results). There-
fore, we conclude that the high number of Y27632-treated
cells present in the filter is probably the result of a defect in
detachment.
ROCK Involvement in Chemotaxis and
Chemokinesis
In the Boyden chamber assay, neutrophils or eosinophils
migrate through a three-dimensional filter of nitrocellulose.
Migration of cells in filters occurs under less stringent cir-
cumstances. The main difference between these experimen-
tal setups is the presence of a two- versus a three-dimen-
sional substrate. Eosinophils migrating through filters show
efficient migration after stimulation with PAF or IL-5, which
is not the case when migrating over albumin-coated glass
coverslips. Preincubation of eosinophils with the ROCK-
inhibitor Y27632 leads to a dose-dependent inhibition of
chemotaxis toward PAF (Figure 5A). When serum is present
in both the upper and the lower wells of the chemotaxis
chamber, chemokinesis is observed. The ROCK-inhibitor is
effective in inhibition of chemokinesis stimulated by IL-5 or
serum as well as chemotaxis stimulated by PAF. The ob-
served IC50 for the different stimuli is 3–10 mM, in range
with the published value in smooth muscle cells (Uehata et
al., 1997). Similarly, chemotaxis of neutrophils induced by
fMLP is inhibited by Y27632 (Figure 5B). Thus, activation of
ROCK is necessary for the migration of granulocytes.
Figure 5. Granulocyte chemotaxis in the presence of ROCK-inhib-
itor Y27632. (A) Eosinophils migrating in the Boyden chamber were
stimulated with PAF (1027 M) present in the lower wells, IL-5 (10210
M) in the upper well, or with serum (10%) in both wells. (B) Boyden
chamber chemotaxis assay of neutrophils stimulated with fMLP
(1028 M). Y27632 pretreatment was in all cases for 30 min. The
results are expressed as chemotactic index (mean 6 SEM of 2–6
experiments performed in duplicate).
Figure 4. Transendothelial migration of eosinophils in the pres-
ence of Y27632. Eosinophils migrating over confluent monolayers of
human umbilical vein endothelial cells (details in MATERIALS
AND METHODS) were stimulated with PAF (1027 M) or eotaxin
(1027 M). Pretreatment of the eosinophils with Y27632 was for 30
min as indicated (in mM). After 1 h of migration, the cells were taken
out of the lower wells, filters, and upper wells and separately
quantified with the use of calcein. The results are expressed as
percentage of total cells (mean 6 SEM) of a representative experi-
ment performed in duplicate.
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ROCKs Influence Attachment
Activation of ROCK leads to phosphorylation of MLC, an
event that is correlated with force generation and contrac-
tion of cells. It can be envisioned how a higher contrac-
tility of a cell leads to better detachment from its sub-
strate. Alternatively, RhoA activation is implicated in
adhesion of neutrophils (Laudanna et al., 1996). Therefore,
RhoA’s downstream kinase ROCK could elicit a signal
toward adhesion molecules, thereby regulating the affin-
ity for ligands present on the substrate. To address this
hypothesis, we measured the effect of ROCK-inhibitor on
the activity of two important adhesion molecules present
on eosinophils (Weber et al., 1996): a4b1-integrin (binding
to VCAM) and b2-integrins (binding to ICAM-1). Figure 6
shows that Y27632 has an inhibitory effect on the activity
of a4- as well as b2-containing integrins. The effects of
Y27632 are rather small, as seen by the partial inhibition
of cells binding to ICAM and the fact that inhibition of
binding to VCAM is only observed at limiting ligand
concentration. This means that ROCK activation does in-
fluence attachment as well as detachment.
Is RhoA Activity Sufficient to Stimulate
Detachment?
To investigate whether RhoA activation is the primary
mechanism of detachment, we transduced eosinophils with
activated RhoA (V14RhoA). Because classic transfection pro-
cedures are unsuccessful on these primary cells, we made
use of the cell permeability of tat-fusion proteins (Nagahara
et al., 1998). When tat-V14RhoA is applied to the cells in the
presence of the chemoattractant PAF, tat-V14RhoA is able to
replace serum and stimulate detachment (Figure 7B). The
experiments are performed in the continuous presence of
tat-fusion protein to avoid diffusion out of the cell. The
stimulation of detachment increases in time, probably due to
a higher concentration of tat-V14RhoA in the cell, but de-
creases again after ;45 min (Figure 7E). As a control, a
fusion-protein containing syntenin is used, which had no
effect on detachment (Figure 7, C and D). To substantiate the
hypothesis we did the reverse experiment. Tat-N19RhoA
was applied to the cells in the presence of serum. This
resulted in an inhibition of detachment (Figure 7F), whereas
in the control situation, eosinophils incubated with tat-syn-
tenin in the presence of serum show normal detachment.
From these results we conclude that activation of the Rho-
ROCK pathway alone is necessary but not sufficient to stim-
ulate detachment. Other, as yet unidentified signals, elicited
by the stimulus PAF contribute to the stimulation of detach-
ment.
DISCUSSION
We have shown that the Rho-ROCK pathway is essential in
the regulation of the process of uropod detachment or rear
release, a field in migration research that has not received
much attention until now. One of the possible explanations
is the difficulty in monitoring rear release. The only method
to appreciate cellular rear release is through time-lapse (vid-
eo) microscopy of cells migrating on a two-dimensional
substratum. Highly motile cells that are detachment-defec-
tive can easily be recognized by direct viewing of the cells.
Such a cell has a uropod that is firmly attached to the
substratum. Under high-magnification viewing it becomes
clear that the cell body is moving actively around the cell.
We found that high motility and stimulation of rear re-
lease can be separated. In eosinophils, a situation of high
motility and no detachment is found in the absence of se-
rum. This situation can be mimicked in neutrophils by inhi-
bition of RhoA or ROCK. This leads us to the conclusion that
motility and rear release have a different molecular basis.
The mechanisms underlying rear release are largely un-
known. Based on our findings, ROCK-mediated cytoskeletal
contraction turns out to be very important. The measure-
ment of force generation in cells is expected to correlate with
rear release stimulation.
A second mechanism that may explain rear release in-
volves integrin modulation. In this model, ligand-stimulated
signaling is responsible for affinity or avidity changes of
integrins (Lauffenburger and Horwitz, 1996; Hughes and
Pfaff, 1998). It is clear that the strength of adhesions deter-
mines the migration speed of cells (Palecek et al., 1997): at
decreased adhesive strength migration speed is enhanced.
This occurs in a situation without addition of external stim-
uli, which implies no changes in cytoskeletal contraction.
Figure 6. Adhesion of eosinophils to ICAM-1 or VCAM. Eosino-
phils were calcein-loaded, incubated for 30 min with Y27632 at the
indicated concentrations (between brackets, in mM), or with neu-
tralizing antibodies against a4- (HP2/1) or b2- (IB4) integrins. Then
the cells were placed in 96-well plates coated with ICAM-1 (5–10
mg/ml) or VCAM (0.1–5 mg/ml) containing control buffer or serum-
containing buffer and incubated for 5 min at 37°C. The cells were
washed and lysed and fluorescence intensity was measured. The
results are expressed as percentage of maximal binding (mean 6
SEM of 2–5 experiments performed in duplicate).
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Whether RhoA signaling plays a role in integrin modulation
is still a debate. RhoA was found to be important for b2-in-
tegrin–dependent lymphocyte aggregation (Tominaga et al.,
1993) and b1- and b2-integrin–dependent leukocyte adhe-
sion (Laudanna et al., 1996) but not for inside-out signaling
toward platelet aIIbb3 (Leng et al., 1998).
From previous work we know that interference with the
ligand-binding capacity of a4-containing integrins can im-
prove rolling of eosinophils (Ulfman et al., 1999) and rear
release and migration of the cells (our unpublished results).
We found a contribution of Rho’s immediate downstream
target ROCK in signaling toward a4b1- or b2-inte-
grin–dependent attachment. This means that at the same
time ROCK stimulates detachment and attachment. Detach-
ment of the rear of the cell leads to migration, not necessarily
to detachment of the entire cell. This can be seen in Figure 6:
serum stimulation, which very efficiently stimulates detach-
ment of the uropod, leads to increased adhesion, i.e., attach-
ment. Adhesion per se does not correlate with migration
properties of cells. Whether integrins are turned off during
rear release has to be further explored.
In migrating cells, Rac and Cdc42 are responsible for
lamellipodial protrusions, whereas RhoA regulates uropod
detachment by stimulation of actomyosin filament contrac-
tion. Coordination of the activity of these three GTPases is
necessary for optimal migration. In adherent cells that con-
tain focal adhesions, Rac is able to counteract Rho-stimu-
lated formation of stress fibers and focal adhesions directly
or through activation of PAK (Sanders et al., 1999). In leu-
kocytes however, focal adhesions are not present. Here, the
formation of contractile forces is enough to ensure adhesive
release and Rac or Cdc42 may be activated in concert with
RhoA (Geijsen et al., 1999). Clearly, the adhesive state of cells
influences RhoA activation by soluble factors (Ren et al.,
1999). In conclusion, our results point to an essential role for
the Rho-ROCK pathway in migration of leukocytes, namely
in the relatively unknown process of rear release.
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